Fidelity Select Pharmaceuticals (FPHAX) Research
This fund typically allocates a minimum of 80% of its capital to entities involved in the pharmaceutical sector, encompassing activities from scientific discovery and development to manufacturing and distribution of various medicinal products. Its holdings include both domestic and international companies, with the portfolio primarily consisting of common equities. Investment decisions are guided by a thorough fundamental analysis, assessing aspects like a company's financial health, its standing within the industry, and broader market and economic trends. It operates as a non-diversified portfolio.
Market snapshot
- Symbol
- FPHAX
- Price
- $32.66
- Day change
- -1.92%
- Market cap
- $1.2B
- 52-week range
- 23.42-33.95
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Acadian Emerging Markets Investor (AEMGX)
- Acadian Emerging Markets Portfolio Class I (AEMZX)
- American Century One Choice Portfolio: Conservative Investor Class (AOCIX)
- American Century One Choice 2040 Ptf Investor Class (ARDVX)
- DFA Commodity Strategy Portfolio (DCMSX)
- DFA Em Mkts Sustnby Cor 1 Instl (DESIX)
- DFA International Large Cap Growth Portfolio (DILRX)
- MainStay Epoch U.S. Equity Yield Fd Cl A (EPLPX)
Open Fidelity Select Pharmaceuticals (FPHAX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.